Tom Hensel

Tom Hensel is an accomplished professional in strategic management and corporate development with extensive experience in mergers and acquisitions, venture investing, and corporate strategy. Currently serving as the Director of Strategy & Corporate Development at Insulet Corporation since March 2021, responsibilities include M&A, partnership development, competitive intelligence, and ad hoc analysis. Prior to this role, Tom held the position of Manager of Business Development, Licensing and Strategy at AngioDynamics from July 2014 to September 2024, where duties encompassed IP licensing, due diligence, and business case development. Tom's career began at BST Valuation & Litigation Advisors, LLC, where services focused on business valuation in various contexts. Tom holds a Bachelor of Science degree in Accounting from Canisius University.